Asplin C M, Faria A C, Carlsen E C, Vaccaro V A, Barr R E, Iranmanesh A, Lee M M, Veldhuis J D, Evans W S
Department of Internal Medicine, Health Sciences Center, Charlottesville, Virginia.
J Clin Endocrinol Metab. 1989 Aug;69(2):239-45. doi: 10.1210/jcem-69-2-239.
The mechanisms responsible for the elevated levels of circulating GH observed in diabetes mellitus (DM) remain incompletely defined. To assess the episodic fluctuations in serum GH as a reflection of hypothalamic-pituitary activity, we accumulated GH concentration-time series in a total of 48 adult men and women with and without insulin-dependent DM by obtaining serum samples at 10-min intervals over 24 h. Significant pulses of GH release were subsequently identified and characterized by an objective, statistically based pulse detection algorithm (Cluster) and fixed circadian (24-h) periodicities of secretory activity, resolved using Fourier expansion time-series analysis. Compared to those in age-matched controls, integrated 24-h concentrations of GH were 2- to 3.5-fold higher in diabetic men (P = 0.002) and women (P = 0.0005). Both men and women with DM had over 50% more GH pulses per 24 h than their non-DM counterparts. In addition, maximal GH pulse amplitude was markedly elevated in the men and women with DM (P = 0.0019 and 0.0189, respectively). That the increase in maximal pulse amplitude was accounted for by greater baseline levels was documented by a higher interpulse valley mean GH concentration in the diabetics compared to the controls (P = 0.0437 and 0.0056, men and women, respectively) and the absence of any difference in incremental pulse amplitude for either sex (P greater than 0.05). DM men had larger GH pulse areas (P = 0.039) than control men, apparently accounted for by greater pulse width (P = 0.0037). Pulse areas in DM and non-DM women were indistinguishable. Time-series analysis revealed that the 24-h (circadian) rhythms of serum GH concentrations exhibited significantly increased amplitudes in the diabetic group as a whole (compared to the controls, P = 0.011). However, the times of maximal GH concentrations (acrophases) were not significantly different. As a group, serum insulin-like growth factor-I was lower in DM vs. non-DM individuals (P = 0.0014), although when separated by sex this difference did not reach statistical significance in women (P = 0.317). The present data confirm the higher circulating levels of GH previously reported to occur in individuals with poorly controlled DM. The altered frequency of GH pulses together with enhanced interpulse GH concentrations and an amplified circadian GH rhythm are compatible with hypothalamic dysfunction associated with dysregulation of somatostatin and/or GHRH secretion.(ABSTRACT TRUNCATED AT 400 WORDS)
糖尿病(DM)患者循环生长激素(GH)水平升高的机制尚未完全明确。为评估血清GH的间歇性波动以反映下丘脑 - 垂体活动,我们通过在24小时内每隔10分钟采集血清样本,积累了48名成年男性和女性(有或无胰岛素依赖型DM)的GH浓度 - 时间序列。随后通过基于统计学的客观脉冲检测算法(Cluster)识别并表征了显著的GH释放脉冲,并使用傅里叶展开时间序列分析解析了分泌活动的固定昼夜(24小时)周期性。与年龄匹配的对照组相比,糖尿病男性(P = 0.002)和女性(P = 0.0005)的24小时GH综合浓度高出2至3.5倍。患有DM的男性和女性每24小时的GH脉冲比非DM者多50%以上。此外,患有DM的男性和女性的最大GH脉冲幅度显著升高(分别为P = 0.0019和0.0189)。糖尿病患者的脉冲间谷值平均GH浓度高于对照组(男性和女性分别为P = 0.0437和0.0056),且两性的增量脉冲幅度无差异(P大于0.05),这表明最大脉冲幅度的增加是由更高的基线水平所致。糖尿病男性的GH脉冲面积(P = 0.039)大于对照男性,这显然是由于脉冲宽度更大(P = 0.0037)。糖尿病和非糖尿病女性的脉冲面积无差异。时间序列分析显示,糖尿病组血清GH浓度的24小时(昼夜)节律的幅度整体显著增加(与对照组相比,P = 0.011)。然而,最大GH浓度的时间(峰相位)无显著差异。作为一个整体,DM个体的血清胰岛素样生长因子 - I低于非DM个体(P = 0.0014),尽管按性别分开时,这种差异在女性中未达到统计学显著性(P = 0.317)。目前的数据证实了先前报道的血糖控制不佳的个体中循环GH水平较高。GH脉冲频率的改变、脉冲间GH浓度的增加以及昼夜GH节律的增强与下丘脑功能障碍以及生长抑素和/或生长激素释放激素分泌失调有关。(摘要截断于400字)